Skip to main content
Alfresa Holdings Corporation logo

Alfresa Holdings Corporation — Investor Relations & Filings

Ticker · 2784 ISIN · JP3126340003 T Wholesale and retail trade
Open in API
Filings indexed 66 across all filing types
Latest filing 2024-11-12 Regulatory Filings
Country JP Japan
Listing T 2784

About Alfresa Holdings Corporation

https://www.alfresa.com/eng/

Alfresa Holdings Corporation is a healthcare group that manages subsidiaries engaged in the wholesale, manufacturing, import, and export of pharmaceuticals, medical devices, and diagnostic reagents. The company's core business is pharmaceutical wholesaling, focusing on efficient supply chain management and stable delivery to medical institutions and pharmacies. In addition to its distribution network, the group also manufactures its own pharmaceutical products and operates a chain of dispensing pharmacies. Alfresa is committed to supporting the medical supply chain infrastructure, exploring innovative solutions such as drone technology for delivering pharmaceuticals.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the company's semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like an interim/semi-annual report. H1 22
2024-11-12 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled with Japanese headers indicating it is a '臨時報告書' (Extraordinary Report) submitted to the Kanto Local Finance Bureau Director on June 27, 2024. Section 1 explicitly states the reason for filing is that resolutions were passed at the Annual General Meeting (定時株主総会) held on June 26, 2024, citing relevant Japanese financial regulations (FSA Ordinance Article 19, Paragraph 2, Item 9-2). Section 2 details the resolutions, which include the election of 11 Directors and 1 Auditor, along with the vote counts (votes for, against, abstentions) and the final result ('可決' - Approved). This content—reporting the specific resolutions and voting results of a shareholder meeting—perfectly matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to the AGM, the focus is on the official voting outcome report, not the presentation materials (AGM-R).
2024-06-27 Japanese
内部統制報告書－第21期(2023/04/01－2024/03/31)
Governance Information Classification · 1% confidence The document explicitly states in the header section ("【提出書類】") that it is an "内部統制報告書" (Internal Control Report). It references the legal basis under the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項) and details the scope, criteria, and conclusion regarding the assessment of internal controls over financial reporting as of the fiscal year-end (March 31, 2024). This content aligns perfectly with the description of an Audit Report / Information (AR), which covers internal or regulatory stress tests and applied accounting principles, although this specific document is an Internal Control Report, which falls under the scope of AR in this classification scheme, as it is a formal report on internal controls rather than a full annual report (10-K) or a simple announcement.
2024-06-26 Japanese
有価証券報告書－第21期(2023/04/01－2024/03/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the header information for the fiscal year ending March 31, 2024, and includes XBRL-style metadata tags indicating it is a comprehensive annual filing for Alfresa Holdings Corporation. It is not an announcement, but the full report itself. FY 2024
2024-06-26 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document is extremely short (694 characters) and contains a structured header typical of Japanese regulatory filings, specifically mentioning '【提出書類】確認書' (Filing Document: Confirmation Document) and referencing the Financial Instruments and Exchange Act ('金融商品取引法'). The core content confirms that the President and Vice President have verified the appropriateness of the contents of the company's '第21期(自 2023年４月１日 至 2024年３月31日)の有価証券報告書' (21st Fiscal Year Securities Report). This document is not the full Annual Report (10-K) or Interim Report (IR), but rather a formal confirmation statement regarding the accuracy of those reports, filed with the Kanto Local Finance Bureau. This type of formal confirmation or certification document, which is short and relates to the accuracy of a primary filing, fits best under the general 'Regulatory Filings' category (RNS) as it doesn't match the specific definitions for AR, ER, or others, and it is not an announcement of a report release (RPA). FY 2024
2024-06-26 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is extremely short (692 characters) and contains a table structure typical of a cover page for a regulatory filing in Japan, specifically mentioning "【提出書類】確認書" (Document Submitted: Confirmation Document) and referencing the Financial Instruments and Exchange Act. The main body confirms that the President and CFO have verified the appropriateness of the "第21期第３四半期...の四半期報告書" (Quarter 3 of the 21st Fiscal Period... Quarterly Report). Since this document is a *confirmation* of the Quarterly Report, and not the comprehensive report itself, it fits the definition of an announcement or supplementary material related to a filing. Given the context of confirming a Quarterly Report, the most appropriate classification among the provided options is 'Interim / Quarterly Report' (IR) if it were the report, but since it is a confirmation document related to a quarterly filing, and it is very short, it is likely a regulatory filing announcement or a specific confirmation document. However, the core subject matter is the Quarterly Report. In many contexts, a document confirming the accuracy of a quarterly report is filed alongside or instead of the main report if it's a specific certification. Given the options, and recognizing that the subject is the Quarterly Report, if this were a full report, it would be IR. Since it is a confirmation document related to the quarterly report, and it is not a general announcement (RPA/RNS), it is best classified as the underlying report type it certifies, or if a specific certification type existed, that would be used. Since 'IR' (Interim / Quarterly Report) is the closest thematic match, and this is a formal regulatory submission, I will lean towards IR, assuming this confirmation is filed as part of the required quarterly disclosure package, although RPA/RNS are also possibilities if this were purely an announcement of the confirmation filing. Given the explicit reference to the 'Quarterly Report' verification, IR is the strongest thematic fit for the underlying subject matter.
2024-02-14 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.